Vanessa Gómez-Verdejo

Lucía González-Zamorano, Nuria Balbás-Esteban, Vanessa Gómez-Verdejo et al.

Multimodal clinical data are characterized by high dimensionality, heterogeneous representations, and structured missingness, posing significant challenges for predictive modeling, data integration, and interpretability. We propose BIONIC (Bayesian Integration of Nonlinear Incomplete Clinical data), a unified probabilistic framework that integrates heterogeneous multimodal data under missingness through a joint generative-discriminative latent architecture. BIONIC uses pretrained embeddings for complex modalities such as medical images and clinical text, while incorporating structured clinical variables directly within a Bayesian multimodal formulation. The proposed framework enables robust learning in partially observed and semi-supervised settings by explicitly modeling modality-level and variable-level missingness, as well as missing labels. We evaluate BIONIC on three multimodal clinical and biomedical datasets, demonstrating strong and consistent discriminative performance compared to representative multimodal baselines, particularly under incomplete data scenarios. Beyond predictive accuracy, BIONIC provides intrinsic interpretability through its latent structure, enabling population-level analysis of modality relevance and supporting clinically meaningful insight.

Albert Belenguer-Llorens, Carlos Sevilla-Salcedo, Jussi Tohka et al.

We present BALDUR, a novel Bayesian algorithm designed to deal with multi-modal datasets and small sample sizes in high-dimensional settings while providing explainable solutions. To do so, the proposed model combines within a common latent space the different data views to extract the relevant information to solve the classification task and prune out the irrelevant/redundant features/data views. Furthermore, to provide generalizable solutions in small sample size scenarios, BALDUR efficiently integrates dual kernels over the views with a small sample-to-feature ratio. Finally, its linear nature ensures the explainability of the model outcomes, allowing its use for biomarker identification. This model was tested over two different neurodegeneration datasets, outperforming the state-of-the-art models and detecting features aligned with markers already described in the scientific literature.